Doctor profile · Federal record
Dr. JOSE MARTINEZ, MD
Ophthalmology Physician (CMS: OPHTHALMOLOGY) · Retina Specialist (Ophthalmology) Physician · AUSTIN, TX
- NPI 1679545370
- Accepts Medicare
- MIPS 76.1 / 100 · 2023
- 38 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
801 W 38TH ST, SUITE 200
AUSTIN, TX 787051169
(512) 451-0103
fax (512) 451-2741
Credentials & registration
- NPI registered
- February 2006 — 20 yrs on file
- Profile last updated
- May 4, 2017
- Year of graduation
- 1988 — 38 yrs since
- Specialty taxonomy
- 207W00000X — NUCC code
- State license (1)
- Texas #H6411
- Medicaid (2)
- TX #139156717 · TX #139156713
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1679545370. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
20,534
Distinct HCPCS
10
Medicare allowed
$4,792,133
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J2777 |
Injection, faricimab-svoa, 0.1 mg | 8,041 | 34 | $37 | |
J0178 |
Injection, aflibercept, 1 mg | 2,768 | 262 | $869 | |
92134 |
Imaging of retina | 2,369 | 815 | $40 | |
J2781 |
Injection, pegcetacoplan, intravitreal, 1 mg | 2,101 | 79 | $151 | |
67028 |
Injection of drug into eye | 1,733 | 386 | $131 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 648 | 386 | $91 | |
Q5128 |
Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 557 | 45 | $267 | |
92014 |
Established patient complete exam of visual system | 450 | 415 | $128 | |
92235 |
Exam of retinal blood vessels using a special camera after injection of a dye | 421 | 326 | $140 | |
J3490 |
Unclassified drugs | 417 | 159 | $2,410 |
In context: peer comparison
Among 40 peers in this city , average services per provider: 423. This provider delivers 49× the peer median.Open Payments
Industry payments received
All-time total
$14,109
Transactions
22
Manufacturers
8
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 8 | $13,058.96 | |
| ABBVIE INC. | 1 | $500.15 | |
| Regeneron Pharmaceuticals, Inc. | 2 | $173.86 | |
| Genentech USA, Inc. | 5 | $169.51 | |
| Genentech, Inc. | 1 | $78.55 | |
| Astellas Pharma US Inc | 2 | $65.27 | |
| Bausch & Lomb Americas Inc. | 2 | $47.61 | |
| Biogen, Inc. | 1 | $15.20 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
295
Patients
94
Total drug cost
$17,416
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ketorolac Tromethamine | Generic | 87 | 38 | $2,767 |
| Prednisolone Acetate | Generic | 61 | 22 | $3,498 |
| Neomycin-Polymyxin-Dexameth (Neomycin/Polymyxin B/Dexametha) | Brand | 46 | 34 | $737 |
| Timolol Maleate | Generic | 29 | 0 | $513 |
| Bromfenac Sodium | Generic | 26 | 0 | $3,343 |
| Prednisone | Generic | 17 | 0 | $140 |
| Prolensa (Bromfenac Sodium) | Brand | 17 | 0 | $6,070 |
| Latanoprost | Generic | 12 | 0 | $349 |